Cargando…

Pharmacist's perspective on HCQ treatment of COVID‐19

Detalles Bibliográficos
Autores principales:	Wang, Ya‐Ling, Wang, Shih‐Han, Yang, Ai‐Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323069/ https://www.ncbi.nlm.nih.gov/pubmed/32533592 http://dx.doi.org/10.1002/kjm2.12249

Ejemplares similares

Effect of quantitative real-time RT-PCR reaction sensitivity in determining the efficacy of HCQ prophylaxis for COVID-19
por: Gouda, Divakara, et al.
Publicado: (2020)

Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards
por: Garg, Shivani, et al.
Publicado: (2023)

Hydroxychloroquine (HCQ): real treatment or false hope?
por: El Bakkouri, Karim
Publicado: (2021)

Molecular Insights into the MAPK Cascade during Viral Infection: Potential Crosstalk between HCQ and HCQ Analogues
por: Mohanta, Tapan Kumar, et al.
Publicado: (2020)

Quantitative Fundus Autofluorescence in HCQ Retinopathy
por: Greenstein, Vivienne C., et al.
Publicado: (2020)

The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 –a systematic review and meta-analysis
por: Choudhuri, Anirban Hom, et al.
Publicado: (2021)

Can HCQ Be Considered a “Safe Weapon” for COVID-19 in the Indian Population?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers
por: Jha, Sujeet, et al.
Publicado: (2021)

HCQ induced QT prolongation- Primum non nocere
por: Mahendran, A.J., et al.
Publicado: (2020)

HCQ use not protective against SARS-CoV-2
por: Onuora, Sarah
Publicado: (2020)

The ‘myth of Hydroxychloroquine (HCQ) as post-exposure prophylaxis (PEP) for the prevention of COVID-19’ is far from reality
por: Dhibar, Deba Prasad, et al.
Publicado: (2023)

Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19
por: Bhat, Shubha, et al.
Publicado: (2021)

Long Term Pharmacological Perturbation of Autophagy in Mice: Are HCQ Injections a Relevant Choice?
por: Masson, Jean-Daniel, et al.
Publicado: (2020)

Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection
por: Boretti, Alberto
Publicado: (2022)

Further discussion on glucocorticoid treatment of COVID-19
por: Feng, Yun’ai, et al.
Publicado: (2022)

Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy
por: Krueger, Janna, et al.
Publicado: (2021)

MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition
por: Silvis, Mark R., et al.
Publicado: (2023)

COVID-19: sleep research perspectives
por: Najaﬁ, Arezu, et al.
Publicado: (2020)

Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design
por: Sinha, Meetali, et al.
Publicado: (2021)

Successful treatment of a critical COVID-19 patient with tocilizumab
por: Tsao, Shih-Ming, et al.
Publicado: (2021)

Secure the availability of labor: Extension of annual paid leave settlement between healthcare workers and employers is good for post COVID-19 recovery
por: Wang, Chiao-Ling, et al.
Publicado: (2020)

Ethical Guidelines and Moral Distress During the COVID-19 Pandemic: The Trainees’ Perspective
por: Han, Jason J., et al.
Publicado: (2021)

How the Covid-19 pandemic affects our perspective on the medical treatment of acute appendicitis in children
por: Boleken, Mehmet Emin, et al.
Publicado: (2022)

Familial cluster of pneumonia and asymptomatic cases of COVID-19 in Taiwan
por: Chiu, Chun-Hsiang, et al.
Publicado: (2020)

The great challenge of managing recipients of hematopoietic stem cell transplantation combined with COVID-19
por: Lu, Xuan, et al.
Publicado: (2020)

The necessity of early anti-inflammatory therapy initiation in cases with mild-to-moderate COVID-19: A personal experience from an attending pharmacist and his resident
por: Parisa, Ghasemiyeh, et al.
Publicado: (2021)

Healthcare providers’ perspective of COVID-19 pandemic on cancer treatment, screening & early detection services in India
por: Kaushik, Aprajita, et al.
Publicado: (2022)

Repurposing existing drugs for COVID-19: an endocrinology perspective
por: Cadegiani, Flavio A.
Publicado: (2020)

Coronavirus Disease (COVID-19) in Children: Indian Perspectives
por: Senthilkumaran, Subramanian, et al.
Publicado: (2020)

An American's perspective living through COVID-19 in Taiwan
por: Hughes, Michael W., et al.
Publicado: (2020)

Mitigate risks of medication interruption due to COVID‐19 for elderly with chronic diseases
por: Hsiao, Shih‐Huai, et al.
Publicado: (2020)

COVID 19 vaccination and people with disability: Australian perspective
por: Shoib, Sheikh, et al.
Publicado: (2022)

Biomedical waste amid COVID-19: perspectives from Bangladesh
por: Rahman, Md Mostafizur, et al.
Publicado: (2020)

Poliomyelitis amidst COVID-19 pandemic in Pakistan: A perspective
por: Shrestha, Abhigan B., et al.
Publicado: (2023)

Role of Clinical Pharmacist in Cosmeto-vigilance of Misuse and Abuse of Topical Corticosteroids
por: Ashique, K T, et al.
Publicado: (2017)

Is it safe to fly? Consideration of COVID-19 risk mitigation strategies from the travellers’ perspective
por: Holdik, Elisa Nicola, et al.
Publicado: (2021)

A Study on Hydroxychloroquine (HCQ) as prophylaxis among Health care worker (HCW) for SARS -Co V-2 infection
por: Ghosh, Anindya, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Retinopathy of Prematurity Practice: An Indian Perspective
por: Katoch, Deeksha, et al.
Publicado: (2020)

Health democracy in time of COVID-19: a perspective from France
por: Brocard, Eva, et al.
Publicado: (2021)

Unveiling the underside of COVID-19: a pediatric perspective from Pakistan
por: Kumar, Sanjesh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f067ti2tlqd1s18lqchqi5hcfb